These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22674083)

  • 1. Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity.
    Asanuma M; Miyazaki I; Kikkawa Y; Kimoto N; Takeshima M; Murakami S; Miyoshi K
    Neurochem Res; 2012 Sep; 37(9):1944-51. PubMed ID: 22674083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity.
    Takeshima M; Murata M; Urasoe N; Murakami S; Miyazaki I; Asanuma M; Kita T
    Neurol Res; 2011 Dec; 33(10):1050-6. PubMed ID: 22196758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.
    Asanuma M; Miyazaki I
    BMC Neurosci; 2016 Jul; 17(1):52. PubMed ID: 27456338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Miyoshi K; Ogawa N; Murata M
    Neurosci Res; 2008 Jan; 60(1):106-13. PubMed ID: 18022268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
    Maharaj DS; Saravanan KS; Maharaj H; Mohanakumar KP; Daya S
    Neurochem Int; 2004 Apr; 44(5):355-60. PubMed ID: 14643753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.
    Asanuma M; Miyazaki I; Ogawa N
    Neurotox Res; 2003; 5(3):165-76. PubMed ID: 12835121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.
    Pardo B; Mena MA; Casarejos MJ; Paíno CL; De Yébenes JG
    Brain Res; 1995 Jun; 682(1-2):133-43. PubMed ID: 7552304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin, but not the more selective cyclooxygenase (COX)-2 inhibitors meloxicam and SC 58125, aggravates postischaemic cardiac dysfunction, independent of COX function.
    Heindl B; Becker BF
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):233-40. PubMed ID: 11218076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
    Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.
    Miyazaki I; Asanuma M; Hozumi H; Miyoshi K; Sogawa N
    FEBS Lett; 2007 Oct; 581(25):5003-8. PubMed ID: 17910954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes.
    Tsubouchi Y; Sano H; Yamada R; Hashiramoto A; Kohno M; Kusaka Y; Kondo M
    Eur J Pharmacol; 2000 May; 395(3):255-63. PubMed ID: 10812057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells.
    Tasaki Y; Omura T; Yamada T; Ohkubo T; Suno M; Iida S; Sakaguchi T; Asari M; Shimizu K; Matsubara K
    Brain Res; 2010 Jul; 1344():25-33. PubMed ID: 20452332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.
    Pedrosa R; Soares-da-Silva P
    Br J Pharmacol; 2002 Dec; 137(8):1305-13. PubMed ID: 12466240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
    Teismann P; Ferger B
    Synapse; 2001 Feb; 39(2):167-74. PubMed ID: 11180504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers.
    Van Ryn J; Kink-Eiband M; Kuritsch I; Feifel U; Hanft G; Wallenstein G; Trummlitz G; Pairet M
    J Clin Pharmacol; 2004 Jul; 44(7):777-84. PubMed ID: 15199082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
    Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs.
    Jones CJ; Streppa HK; Harmon BG; Budsberg SC
    Am J Vet Res; 2002 Nov; 63(11):1527-31. PubMed ID: 12428662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
    Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
    Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity.
    Miyazaki I; Asanuma M; Kikkawa Y; Takeshima M; Murakami S; Miyoshi K; Sogawa N; Kita T
    Glia; 2011 Mar; 59(3):435-51. PubMed ID: 21264950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocolytic effect of the cyclooxygenase-2 inhibitor, meloxicam: studies on uterine contractions in the rat.
    Yousif MH; Thulesius O
    J Pharm Pharmacol; 1998 Jun; 50(6):681-5. PubMed ID: 9680081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.